# Tandem Diabetes Care, Inc. (TNDM) FY2026 Q2 Balance Sheet

- Company: Tandem Diabetes Care, Inc. (TNDM)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001438133-26-000125
- Page: https://plicit.ai/financials/tndm/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/tndm-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 1,154,202,000 US dollars
- **Current assets**: 804,639,000 US dollars
- **Non-current assets**: 349,563,000 US dollars
- **Liabilities**: 1,023,814,000 US dollars
- **Current liabilities**: 253,005,000 US dollars
- **Non-current liabilities**: 770,809,000 US dollars
- **Equity**: 130,388,000 US dollars
- **Short-term investments**: 393,178,000 US dollars
- **Accounts receivable, net**: 162,065,000 US dollars
- **Inventories**: 135,106,000 US dollars
- **Cash and cash equivalents**: 62,818,000 US dollars
- **Prepaid and other current assets**: 51,472,000 US dollars
- **Equity method investment**: 132,271,000 US dollars
- **Operating lease right-of-use assets**: 100,185,000 US dollars
- **Property and equipment, net**: 84,501,000 US dollars
- **Other long-term assets**: 32,606,000 US dollars
- **Other current liabilities**: 81,380,000 US dollars
- **Accounts payable**: 64,130,000 US dollars
- **Employee-related liabilities**: 53,261,000 US dollars
- **Accrued expenses**: 25,539,000 US dollars
- **Operating lease liabilities**: 20,265,000 US dollars
- **Deferred revenue**: 8,430,000 US dollars
- **Convertible senior notes, net - long-term**: 602,577,000 US dollars
- **Operating lease liabilities - long-term**: 116,411,000 US dollars
- **Other long-term liabilities**: 44,045,000 US dollars
- **Deferred revenue - long-term**: 7,776,000 US dollars
- **Commitments and contingencies (Note 14)**: 0 US dollars
- **Additional paid-in capital**: 1,418,011,000 US dollars
- **Accumulated other comprehensive income**: 6,403,000 US dollars
- **Common stock, $0.001 par value; 200,000 shares authorized, 69,540 and 68,291 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 70,000 US dollars
- **Accumulated deficit**: negative 1,294,096,000 US dollars
- **Gross equity (calculated)**: 1,424,484,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.